Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Pharmaxis Ltd ( (AU:SNT) ) is now available.
Syntara Limited has announced the issuance of 551,501 performance rights as part of an employee incentive scheme. These securities are unquoted and subject to a restriction on transfer until the restriction ends, indicating a strategic move to retain and motivate employees, potentially impacting the company’s operational efficiency and market competitiveness.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.25 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 11,218,662
Technical Sentiment Signal: Sell
Current Market Cap: A$82.87M
Find detailed analytics on SNT stock on TipRanks’ Stock Analysis page.